Renerve raises AU$7M in Australian IPO for nerve repair
Renerve raises AU$7M in Australian IPO for nerve repair
Syncell raises $15M series A for precise spatial proteomics tech
Syncell raises $15M series A for precise spatial proteomics tech
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Zhongzhi drops $3M in Gabaeron series A for stem cell AD therapy
Australia’s Celosia heads toward clinic with gene therapy for ALS
Australia’s Celosia heads toward clinic with gene therapy for ALS
Tuberculosis Bacteria Vulnerable to Substances from Peat Bog Fungi
An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis in humans. The findings from…
Gene and Cell Therapies Take Aim at Parkinson’s Disease
Parkinson’s disease is characterized by the loss of dopamine-producing neurons. The current treatment is oral levodopa, which is taken up by brain neurons and converted to dopamine. But levodopa eventually…
Charles River Introduces Global Biotech Incubator Program
Charles River Laboratories launched the Charles River Incubator Program (CIP), specializing in supporting early-stage biotech companies in the discovery, development, and phase-appropriate manufacturing of advanced therapies. “The Charles River Incubator…
Lymphoma Immunotherapy Enhanced by Enzyme Inhibitor In Preclinical Model, Prompting Pilot Clinical Studies
The results of a preclinical study by lymphoma researchers at Weill Cornell Medicine suggest that an emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of…
Tasca Raises $52 Million to Target Novel Lipid-Bound Protein Pocket in Cancer, Other Diseases
When Milenko Cicmil, PhD, first heard about the technology underlying Tasca Therapeutics, a newly-minted small molecular inhibitor company, he was intrigued. The privately-held company, which launched this week with a…